Your browser doesn't support javascript.
loading
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.
Largeot, Anne; Klapp, Vanessa; Viry, Elodie; Gonder, Susanne; Fernandez Botana, Iria; Blomme, Arnaud; Benzarti, Mohaned; Pierson, Sandrine; Duculty, Chloé; Marttila, Petra; Wierz, Marina; Gargiulo, Ernesto; Pagano, Giulia; An, Ning; El Hachem, Najla; Perez Hernandez, Daniel; Chakraborty, Supriya; Ysebaert, Loïc; François, Jean-Hugues; Cortez Clemente, Susan; Berchem, Guy; Efremov, Dimitar G; Dittmar, Gunnar; Szpakowska, Martyna; Chevigné, Andy; Nazarov, Petr V; Helleday, Thomas; Close, Pierre; Meiser, Johannes; Stamatopoulos, Basile; Désaubry, Laurent; Paggetti, Jérôme; Moussay, Etienne.
Afiliação
  • Largeot A; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Klapp V; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Viry E; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Gonder S; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Fernandez Botana I; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Blomme A; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Benzarti M; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Pierson S; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Duculty C; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium.
  • Marttila P; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Wierz M; Department of Cancer Research, Cancer Metabolism Group, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Gargiulo E; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Pagano G; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • An N; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • El Hachem N; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.
  • Perez Hernandez D; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Chakraborty S; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Ysebaert L; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • François JH; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Cortez Clemente S; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium.
  • Berchem G; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium.
  • Efremov DG; Department of Infection and Immunity, Proteomics of Cellular Signaling, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Dittmar G; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Szpakowska M; Haematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
  • Chevigné A; Laboratoire d'hématologie, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
  • Nazarov PV; Département d'hémato-oncologie, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
  • Helleday T; Département d'hémato-oncologie, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
  • Close P; Luxembourg Institute of Health, Luxembourg, Luxembourg.
  • Meiser J; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Stamatopoulos B; Department of Infection and Immunity, Proteomics of Cellular Signaling, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Désaubry L; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Paggetti J; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Moussay E; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Blood ; 141(26): 3166-3183, 2023 06 29.
Article em En | MEDLINE | ID: mdl-37084385
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Luxemburgo
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Luxemburgo